SCHEMBL4336887

SCHEMBL4336887

Cc1cc(Cl)ccc1OC[C@@H](O)COc1cccc(C[C@H](OC(C)C)C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 2/20 0.47
MRGPRX4 Q96LA9 1/20 0.45
ANO1 Q5XXA6 1/20 0.45
PPARA Q07869 7/20 0.44
PPARG P37231 6/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PPARD Q03181 2/20 0.41
TSHR P16473 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4333304 1.00 SCN4A (0.47) SCN4AMRGPRX4ANO1PPARAPPARG
SCHEMBL4333309 1.00 SCN4A (0.47) SCN4AMRGPRX4ANO1PPARAPPARG
SCHEMBL4333286 0.92 PPARA (0.44) SCN4APPARAPPARGMEN1KMT2A
SCHEMBL4328248 0.91 SCN4A (0.46) SCN4AMRGPRX4ANO1PPARAPPARG
SCHEMBL4335119 0.91 SCN4A (0.46) SCN4AMRGPRX4ANO1PPARAPPARG
SCHEMBL4328252 0.91 SCN4A (0.46) SCN4AMRGPRX4ANO1PPARAPPARG
SCHEMBL4327910 0.91 PPARA (0.51) MRGPRX4PPARAPPARGMEN1KMT2A
SCHEMBL4327644 0.91 PPARA (0.51) MRGPRX4PPARAPPARGMEN1KMT2A
SCHEMBL4327650 0.91 PPARA (0.51) MRGPRX4PPARAPPARGMEN1KMT2A
SCHEMBL4329835 0.90 MRGPRX4 (0.43) MRGPRX4PPARAPPARGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 SCN4A 219/4885MRGPRX4 428/4885ANO1 2379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.